Regulus Therapeutics: $50.9 Million Initial Public Offering

Regulus Therapeutics, developer of pharmaceuticals based on microRNA therapeutics, in its $50.9 million IPO.

Related Contacts
Ken Rollins Partner, San Diego
Related Practices & Industries

Capital Markets